Biological E gets DCGI nod for Phase 3 clinical trials of Corbevax as booster dose
Biological E gets DCGI nod for Phase 3 clinical trials of Corbevax as booster dose - Biological E, Hyderabad-based pharmaceutical company on Tuesday received the emergency-use authorisation for manufacturing and marketing of Corbevax.